Bildkälla: Stockfoto

Alligator Bioscience: Phase II trial with Mitazalimab initiated - Redeye

Redeye comments on the initiation of the planned phase II clinical trial with Mitazalimab. It is a positive signal that shows that the company is now on the right track with its clinical programme.

Redeye comments on the initiation of the planned phase II clinical trial with Mitazalimab. It is a positive signal that shows that the company is now on the right track with its clinical programme.
Börsvärldens nyhetsbrev
ANNONSER